Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Ilias Kanchan's brain tumor refuses to leave London skull
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 63214, member: 636"] Veteran actor Ilias Kanchan is receiving treatment for a brain tumor at Wellington Hospital in London after undergoing surgery on Aug. 5, 2025. His son told reporters at a virtual press conference on Wednesday that surgeons could not completely remove the tumor because doing so risked paralysis and loss of speech or mobility. Professor Demetrius led the operation but extracted only a partial section of the growth. The remaining tumor will be treated through radiation and chemotherapy over six weeks starting this month. Doctors diagnosed the brain tumor at Anwar Khan Modern Hospital in Dhanmondi in early April before the National Institute of Neurosciences confirmed surgery would be dangerous due to the tumor's location near critical nerves. Kanchan traveled to London on April 26 after the diagnosis. His son requested prayers from the Bangladeshi public for a full recovery. Kanchan is known for his road safety advocacy work in Bangladesh. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Ilias Kanchan's brain tumor refuses to leave London skull
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top